Physician profile
Richard L Glowacki
NPI 1679567663
$11,660.96
in general payments reported to CMS, 2019-2025
42 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,631 · 2020: $3,890 · 2021: $720 · 2022: $1,345 · 2023: $1,068 · 2024: $2,015 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,583 · Travel and Lodging: $366 · Education: $116 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,583.06 |
| Travel and Lodging | $366.36 |
| Education | $116.29 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,570.02 | 2019-2025 | |
| Boston Scientific Corporation | $1,293.53 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Neotract INC. | $679.60 | 2019-2020 | |
| Janssen Biotech, INC. | $507.01 | 2019-2024 | Erleada, Akeega |
| Teleflex LLC | $423.72 | 2021-2025 | Barrigel |
| Dornier Medtech America, INC | $410.80 | 2019-2024 | Dornier Medtech |
| Sumitomo Pharma America, INC. | $327.02 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $261.98 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $216.33 | 2019-2025 | Adstiladrin |
| Astellas Pharma US INC | $214.18 | 2021-2025 | Xtandi |
| Abbvie INC. | $199.53 | 2019-2025 | |
| Telix Pharmaceuticals | $196.55 | 2022-2024 | Illuccix |
| Myovant Sciences INC. | $184.33 | 2021-2022 | |
| Medtronic, INC. | $167.89 | 2023 | Interstim, Ligasure |
| Pfizer INC. | $165.90 | 2022-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $163.78 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $155.18 | 2021-2025 | Provenge |
| Procept Biorobotics Corporation | $140.14 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $124.32 | 2022-2025 | |
| Karl Storz Endoscopy-America | $121.87 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $119.66 | 2022-2025 | Keytruda, Bridion, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $103.74 | 2022-2025 | Opdivo |
| Olympus America INC. | $90.83 | 2019-2024 | Hd Camera Head, Uretero-Reno Videoscope |
| Endo USA, INC. | $90.37 | 2024-2025 | Xiaflex |
| Amgen INC. | $78.27 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $63.69 | 2021-2023 | Prolaris |
| Axonics, INC. | $62.61 | 2022-2023 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $61.52 | 2020-2023 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $60.23 | 2023 | Trelstar |
| Progenics Pharmaceuticals, INC. | $57.69 | 2023-2025 | Pylarify |
| Conmed Corporation | $52.79 | 2022-2024 | Airseal |
| Coloplast Corp | $48.00 | 2020-2025 | |
| Allergan, INC. | $46.36 | 2019-2021 | |
| Tolmar, INC. | $35.86 | 2024-2025 | Eligard, Jatenzo |
| Sun Pharmaceutical Industries INC. | $33.57 | 2024-2025 | |
| Calyxo, INC. | $25.44 | 2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $22.71 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $19.55 | 2019 | |
| Cook Medical LLC | $19.36 | 2024 | Litho 150 |
| Becton, Dickinson and Company | $16.71 | 2024 | Bard Urinary Drainage Bag |
| C. R. Bard, INC. & Subsidiaries | $15.84 | 2025 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Glowacki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.